Behcet’s Disease tends to develop in young adults, typically in their 20’s and 30’s, but patients of all ages, gender and races may be affected. The disease is most prevalent in Turkey (approximately 400 cases for every 100,000 individuals). In Middle Eastern countries, males are more commonly affected. In the United States, other Western countries, Japan and Korea, the disease occurs more frequently in women. Prevalence is increasing throughout the world because of better disease recognition and reporting of cases.
Current research suggests viral, bacterial, genetic and environmental factors may play a role in the development of Behcet’s Disease, but no specific cause has been established and no triggers have been identified. Epidemiological studies suggest there are approximately 16,000-20,000 cases of Behcet’s Disease in the United States (approximately 1 case out of every 170,000 individuals). Behcet’s is considered a rare disease in the United States because it affects less than 200,000 people.
Behcet’s Disease is NOT contagious, therefore, it does not spread from one person to another. Symptoms vary from person to person. The most common symptoms include oral ulcers, genital ulcers, inflammation of the eye, skin lesions, and arthritis. Inflammation inside of the eye (anterior or posterior uveitis, retinitis, and iritis) may be serious and lead to loss of vision if untreated. A complete eye exams should be part of the assessment if ocular manifestations are present. Other symptoms of the disease may include blood clots, inflammation in the central nervous system, symptoms of the digestive tract, and rarely, involvement of the kidneys.
Treatment of Behcet’s Disease is symptomatic. It is aimed at reducing symptoms and preventing complications. Stem Cell International can develop a treatment plan for you to potentially reduce the symptoms of Behcet’s Disease. Call us today to schedule a FREE consultation!